Distinct Epigenomic Features in End-Stage Failing Human Hearts
Author(s) -
Mehregan Movassagh,
MunKit Choy,
David A. Knowles,
Lina Cordeddu,
Syed Haider,
Thomas A. Down,
Lee Siggens,
Ana Vujić,
Ilenia Simeoni,
Chris Penkett,
Martin Goddard,
Píetro Lió,
Martin R. Bennett,
Roger Foo
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.040071
Subject(s) - epigenome , epigenomics , dna methylation , biology , genetics , epigenetics , cpg site , human genome , histone , gene , genome , gene expression
The epigenome refers to marks on the genome, including DNA methylation and histone modifications, that regulate the expression of underlying genes. A consistent profile of gene expression changes in end-stage cardiomyopathy led us to hypothesize that distinct global patterns of the epigenome may also exist.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom